Semnur Pharmaceuticals Stock Price, News & Analysis
Company Description
Semnur Pharmaceuticals (OTC Link: SMNR) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $1.8B.
SMNR stock has declined 60.0% over the past year. Shares last traded at $8.00.
On a trailing twelve-month basis, Semnur Pharmaceuticals and diluted earnings per share of $-0.78.
This page provides a comprehensive overview of SMNR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Semnur Pharmaceuticals (SMNR) stock last traded at $8.00. Over the past 12 months, the stock has lost 60.0%. At a market capitalization of $1.8B, SMNR is classified as a small-cap stock with approximately 230.2M shares outstanding.
Latest News
SEC Filings
Semnur Pharmaceuticals has filed 5 recent SEC filings, including 2 Form 8-K, 1 Form ARS, 1 Form DEF 14A, 1 Form 10-K. The most recent filing was submitted on April 30, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SMNR SEC filings →
Financial Highlights
Diluted earnings per share stood at $-0.78. The company generated -$5.9M in operating cash flow. With a current ratio of 0.06, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Semnur Pharmaceuticals (SMNR) currently stands at 1.8 thousand shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Semnur Pharmaceuticals (SMNR) currently stands at 1000.0 days, up 14.3% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 9990.7% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 6.6 to 1000.0 days.
SMNR Company Profile & Sector Positioning
Semnur Pharmaceuticals (SMNR) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.